Trial intelligence / Profile preview

Neo Putty MTA vs Formocresol in Vital Pulpotomy of Mandibular Primary Molars

NCT07437794Not yet recruiting

Sponsor
October University for Modern Sciences and Arts
Start
Mar 2026
Primary completion
Apr 2026
Countries
1
01

Overview

Randomised trial of NeoPUTTY MTA in dental caries (2 arms), sponsored by October University for Modern Sciences and Arts. Primary endpoint: Postoperative pain at 12 months. Planned start Mar 2026; status: not yet recruiting.

02

Drugs

NeoPUTTY MTA
03

Conditions

dental caries

Beyond the preview

Go deeper on NCT07437794.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07437794.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call